Irish medicines body announces 2009 fee increase
This article was originally published in RAJ Devices
Executive Summary
The Irish Medicines Board (IMB) has launched a consultation process on the level of its 2009 fees, proposing their overall increase by 4.9%. “It is essential that increasing costs, arising from issues outside the IMB’s direct control be reflected in an increased fee income to enable it to meet and enhance our service levels to client companies,” the authority has noted.